A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine (NCT07645924)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Acute Treatment of Migraine
🩺 Plain-English Summary (8th-Grade Level)
This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.
Who can join: Review the eligibility criteria below.
Location: Central Research Associates, LLC (CRA) dba Flourish Research — Birmingham, Alabama
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (113 Sites)
Showing the first 25 of 113 sites.
- Central Research Associates, LLC (CRA) dba Flourish Research — Birmingham, Alabama
- AMR Mobile — Mobile, Alabama
- TrialSphere — Chandler, Arizona
- Arkansas Clinical Research — Little Rock, Arkansas
- Axiom Research, LLC — Colton, California
- ProScience Research Group — Culver City, California
- Leading Edge Research LA, LLC — Encino, California
- Axiom Research, Orange County — Irvine, California
- Downtown L.A. Research Center, Inc. — Los Angeles, California
- Clinical Research Institute — Los Angeles, California
- M3 Wake Research - Mission Mental Health (WR-MMH) — Mission Viejo, California
- Excell Research — Oceanside, California
- Empire Clinical Research — Pomona, California
- The Neurology Group — Pomona, California
- Artemis Institute for Clinical Research — Riverside, California
- Acclaim Clinical Research — San Diego, California
- CenExel Sherman Oaks CA (California Neuroscience Research) — Sherman Oaks, California
- Encompass Clinical Research — Spring Valley, California
- Sunwise Clinical Research — Walnut Creek, California
- Diablo Clinical Research — Walnut Creek, California
- Kinetic Clinical Research — West Covina, California
- Focus Clinical Research — West Hills, California
- IMMUNOe Research Centers — Centennial, Colorado
- MCB Clinical Research Centers — Colorado Springs, Colorado
- Advanced Neurosciences Research — Fort Collins, Colorado
📞 Contact the Study Coordinator
Phone: (917) 336-3654
Email: annemarie@kallyope.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Migraine
- A Study of Wearable Devices to Predict Migraines — Rochester, Minnesota
- Treatment for Migraine and Mood — The Bronx, New York
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine — Birmingham, Alabama
- A Study to Evaluate White Matter Hyperintensities in Migraine — Phoenix, Arizona
- Migraine Manager (R01) — Cincinnati, Ohio
- Nerivio Efficacy Under High-Frequency Use — Bridgewater, New Jersey
Explore by condition: All Migraine clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.